about
Role of prostaglandins in neuroinflammatory and neurodegenerative diseasesIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesA small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammationMultifunctional drugs for head injuryOxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammationGlycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes.HDAC6 regulates LPS-tolerance in astrocytes.Insulin resistance in Alzheimer's disease.Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's diseaseImmunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damageThe brain as a target for inflammatory processes and neuroprotective strategies.Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Disruption of neurogenesis by hypothalamic inflammation in obesity or aging.Effects of magnesium deficiency--more than skin deep.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals.Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.Anti-neuroinflammatory Activity of Elephantopus scaber L. via Activation of Nrf2/HO-1 Signaling and Inhibition of p38 MAPK Pathway in LPS-Induced Microglia BV-2 Cells.Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets.Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.P2X(7) Receptors in Neurological and Cardiovascular Disorders.Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model.CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation.Inflammatory Activation of Microglia and Astrocytes in Manganese Neurotoxicity.Investigating pyridazine and phthalazine exchange in a series of iridium complexes in order to define their role in the catalytic transfer of magnetisation from para-hydrogen.Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway.Microglial Activation Results in Inhibition of TGF-β-Regulated Gene Expression.New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part I.Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation.Protective effect of hydrocortisone on iminodipropionitrile-induced neurotoxicity in rats.Central Nervous System Neuron-Glia co-Culture Models and Application to Neuroprotective Agents.Intracellular ion channel CLIC1: involvement in microglia-mediated β-amyloid peptide(1-42) neurotoxicity.The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases.Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.
P2860
Q26863534-5F3F0992-D1D6-4A05-9C87-4515BDB6676AQ28388335-72338783-EC42-4BC8-8E64-F32808A7F61EQ28585972-776CA1B0-29C7-4209-8873-3F425C416266Q30371428-A6ED4507-2FBA-466A-BA8D-F22EECB36FC3Q33714587-01843FAB-8AD1-4487-8274-2A4E5EF14384Q33908462-7B13EBFF-7547-42B2-8F09-9FE1606AD193Q34036799-0B64B667-0FDC-4A65-83B0-04365444FFC8Q34055727-46F62193-A08C-4977-8997-397FD5AD0286Q34622157-792972BF-7CDC-4BA4-AF55-DECBD7F8D984Q36112435-E5AE8293-2846-407B-ACA8-D4441700BD62Q36620651-857C0144-4B73-42E7-BE83-BF1D116CD0E6Q36983964-CB270858-A048-4AE5-9DE0-1CCA2EB19BCEQ37031200-B6CD6438-EB49-41AB-95C1-0073D5507745Q37395599-055D72B2-75D3-406E-B6AD-428CC3734ED5Q37676906-0796F013-0E08-4D4F-9914-4ACEBA6AD2B7Q38072364-E3FCD677-EA1B-4AEF-8AE8-A2F4B143EF52Q38155414-7BF64C45-3818-4927-B098-801FD0A2A724Q38220182-948C7546-56E7-4123-BCDF-2D07C1F7F47FQ38974307-5A80B548-0821-41D6-B0D6-539E1AE43C5BQ39009469-523B611D-C44B-4A59-A4E3-7EDEDFD63A3AQ39942320-E7F6329E-BD52-409B-8605-63AD6039F5B5Q40177595-22FF0063-1592-4702-828D-6D95B18FB80EQ41080735-6404CA8A-12D2-46D7-9FC3-177626635DA7Q41816654-C160C17C-9A46-44D2-854A-9B7E47A7FF3FQ41864750-1F486285-DD10-4909-9D09-85BEDCF9633AQ41966488-A9942078-5C95-49A5-A96D-9C9B2230F6EAQ42265737-F25D3A46-2592-41A4-9620-07271B7D0108Q42549162-712352AF-D0E1-4B1F-B8EE-6D44F2484304Q46124072-E80DA3E5-6A6B-44AE-9D5E-498BBB2473E1Q46309590-9C4BF682-063F-4713-9FE0-58FFBB7202B8Q47134247-CC48E04F-D226-442D-8677-EBA721245644Q47746278-B01A4CB8-69FE-49F0-BFB7-489FA14AFC5FQ47852927-0B49B6F7-72B6-4FC6-8928-142CF597768BQ48148351-411FD523-B26A-4261-AEA0-364C4E9CF1C6Q48158817-A81E604C-6345-49B8-A825-E926CF051E55Q48269041-A0CD326A-B15D-4A41-AC41-BD371297BD68Q49985842-72C9B063-C084-481A-BB20-7D5658BE8185Q50930159-C749028E-40C4-442B-AE2C-27068D2EE8CAQ55020340-6121110A-2023-452B-A3DD-2F8A34154317Q55120072-267BE1C1-5FA5-4A98-A089-411D206898DE
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neuroinflammation: a potential therapeutic target.
@ast
Neuroinflammation: a potential therapeutic target.
@en
type
label
Neuroinflammation: a potential therapeutic target.
@ast
Neuroinflammation: a potential therapeutic target.
@en
prefLabel
Neuroinflammation: a potential therapeutic target.
@ast
Neuroinflammation: a potential therapeutic target.
@en
P2860
P356
P1476
Neuroinflammation: a potential therapeutic target.
@en
P2093
Jeffrey M Craft
Linda J Van Eldik
P2860
P304
P356
10.1517/14728222.9.5.887
P407
P577
2005-10-01T00:00:00Z